...
首页> 外文期刊>Respiratory medicine >Differences in sensitivity, maximal response and position of the concentration-response curve to methacholine between asthmatics, patients with allergic rhinitis and healthy subjects.
【24h】

Differences in sensitivity, maximal response and position of the concentration-response curve to methacholine between asthmatics, patients with allergic rhinitis and healthy subjects.

机译:哮喘患者,过敏性鼻炎患者和健康受试者之间对乙酰甲胆碱的敏感性,最大反应和浓度反应曲线位置的差异。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to detect differences in maximal response and position of the concentration-response curves to methacholine between asthmatics and subjects with allergic rhinitis. A total of 228 adults (107 mild asthmatics, 96 allergic rhinitics and 25 healthy control subjects) were challenged with methacholine. The test was interrupted when FEV1 dropped by more than 40% or when the highest concentration of methacholine (200 mg ml-1) had been administered. Concentration-response curves were characterized by their PC20 (concentration of methacholine that produced 20% fall in FEV1 = airway sensitivity), and if possible, by their EC50 (concentration of methacholine that produced 50% of the maximal response = position) and level of plateau. The proportion of subjects with plateau was significantly lower in asthmatics (18.7%) than in either allergic rhinitics (57.3%) or healthy subjects (92%). It was also significantly lower in allergic rhinitics than in healthy subjects. The level of plateau for asthmatics was (means +/- SD) 31.5 +/- 5.5%, compared with 20.8 +/- 8.1% in allergic rhinitics and 13.7 +/- 6.7% in healthy subjects (P < 0.01). It was also higher in allergic rhinitics than in healthy subjects (P < 0.01). The EC50 values were decreased in asthmatics when they were compared with either allergic rhinitics or healthy subjects (geometric mean EC50: asthmatics = 2.7 mg ml-1, allergic rhinitics = 6.2 mg ml-1, healthy subjects = 8.7 mg ml-1; P < 0.01), but no significant differences were detected between allergic rhinitics and healthy subjects. These results demonstrate that in subjects with allergic rhinitis, the prevalence and level of the plateau on the methacholine concentration-response curve is intermediate between that of asthmatics and normals. Furthermore, while the asthmatic curves differ from normal in having both an increased maximal response and a leftward shift, the rhinitic curves differ only in terms of plateau level. These results suggest that airway responsiveness in asthma and allergic rhinitis may be a consequence of mechanisms that are at least partially different.
机译:这项研究的目的是检测哮喘患者和过敏性鼻炎患者对乙酰甲胆碱的最大反应和浓度反应曲线位置的差异。总共228名成人(107名轻度哮喘患者,96名过敏性鼻炎患者和25名健康对照组)接受了甲胆碱攻击。当FEV1下降超过40%或已施用最高浓度的乙酰甲胆碱(200 mg ml-1)时,测试将中断。浓度-响应曲线的特征在于其PC20(产生FEV1下降20%的乙酰甲胆碱的浓度=气道敏感性),如果可能的话,其EC50(产生最大响应的50%的乙酰甲胆碱的浓度=位置)和高原。哮喘患者的高原受试者比例(18.7%)显着低于过敏性鼻炎患者(57.3%)或健康受试者(92%)。在过敏性鼻炎患者中,它也显着低于健康受试者。哮喘患者的高原水平为(平均+/- SD)31.5 +/- 5.5%,而过敏性鼻炎患者为20.8 +/- 8.1%,健康受试者为13.7 +/- 6.7%(P <0.01)。过敏性鼻炎患者也高于健康受试者(P <0.01)。与过敏性鼻炎或健康受试者相比,哮喘患者的EC50值降低(几何平均EC50:哮喘病= 2.7 mg ml-1,过敏性鼻炎= 6.2 mg ml-1,健康受试者= 8.7 mg ml-1; P <0.01),但过敏性鼻炎患者与健康受试者之间未发现显着差异。这些结果表明,在过敏性鼻炎患者中,乙酰甲胆碱浓度-反应曲线上高原的患病率和水平介于哮喘患者和正常人之间。此外,尽管哮喘曲线在最大反应增加和向左移动方面均与正常曲线不同,但鼻变曲线仅在高原水平方面有所不同。这些结果表明,哮喘和过敏性鼻炎中的气道反应性可能是至少部分不同机制的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号